Eurofins CDMO Alphora announced the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow (CF) technology to its operations. The company is receiving advisory services and research and development funding support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) for this project.
Developed in-house by Eurofins CDMO Alphora scientists, in collaboration with a local university, the new CF equipment line enables substantial intensification of complex manufacturing processes that are traditionally difficult to scale effectively in batch mode. CF technology provides enhanced process control, improved safety, and greater production agility, resulting in more robust and sustainable API manufacturing.